AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,954,023 | +139.3% | 58,403 | +120.9% | 0.00% | – |
| Q2 2023 | $1,234,250 | -79.9% | 26,435 | -83.5% | 0.00% | -100.0% |
| Q1 2023 | $6,134,303 | -45.6% | 160,332 | -22.1% | 0.00% | -50.0% |
| Q4 2022 | $11,282,224 | +8783.6% | 205,880 | +5437.4% | 0.00% | – |
| Q3 2022 | $127,000 | +284.8% | 3,718 | +6.2% | 0.00% | – |
| Q2 2022 | $33,000 | -96.5% | 3,500 | -94.7% | 0.00% | – |
| Q1 2022 | $945,000 | -21.4% | 66,565 | +17.1% | 0.00% | – |
| Q4 2021 | $1,203,000 | +24.4% | 56,840 | +31.4% | 0.00% | – |
| Q3 2021 | $967,000 | +279.2% | 43,252 | +319.9% | 0.00% | – |
| Q2 2021 | $255,000 | -69.3% | 10,301 | -64.0% | 0.00% | – |
| Q1 2021 | $830,000 | +422.0% | 28,609 | +364.9% | 0.00% | – |
| Q4 2020 | $159,000 | +205.8% | 6,154 | +263.9% | 0.00% | – |
| Q3 2020 | $52,000 | +44.4% | 1,691 | +16.5% | 0.00% | – |
| Q2 2020 | $36,000 | +71.4% | 1,452 | +43.6% | 0.00% | – |
| Q1 2020 | $21,000 | -70.8% | 1,011 | -69.0% | 0.00% | – |
| Q4 2019 | $72,000 | -48.2% | 3,261 | -46.6% | 0.00% | – |
| Q3 2019 | $139,000 | +561.9% | 6,108 | +446.3% | 0.00% | – |
| Q2 2019 | $21,000 | – | 1,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |